Guidelines for cardiovascular risk assessment and cholesterol treatment--reply

JAMA. 2014 Jun 4;311(21):2235-6. doi: 10.1001/jama.2014.4075.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiovascular Diseases / prevention & control*
  • Cholesterol, LDL*
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hypercholesterolemia / drug therapy*
  • Hypercholesterolemia / prevention & control*
  • Male
  • Patient-Centered Care*
  • Practice Guidelines as Topic*

Substances

  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors